ABSTRACT. hledium-chain acyl-Coli dehydrogenase (MCAD) deficiency is a frequent and sometimes fatal inherited metabolic disorder of fatty acid &oxidation. eukaryotic espression system was used to study naturally occurring mutations in bICAD. Tho 1263 nuclcotide coding region of human hlCAD cDNA was inserted downstream of the SV40 early promoter for high-level expression in Chinese hamster ovary cells. Both normal hlCAD cDNA and a mutant MCAD cDNA containing the common, disease-causing A to G transition a t position 985 (A985G), which alters a lysine to a glutamic acid (K304E), were inserted into espression vectors. Transient transfection of Chinese hamster ovary cells was performed with the espression constructs. The steady state level of expressed normal hlCAD protein antigen was substantially higher (5-fold) than the expressed mutant protcin. The hlCiiD enzymatic activity in protein extracts from cells containing the expressed normal bICAD cDNA was also much higher (6-fold) than the activity in cells expressing the mutant ILICAD. Therefore, these data confirm that the common K304E mutation causes ILlCAD deficiency primarily by decreased protein stability rather than reduction of catalytic activity and, in fact, demonstrate that the K304E mutant protein has a similar sp act against octanoyl Coii substrate a s the normal protein. (Pediatr Res 34: 694-697, 1993) 
ABSTRACT. hledium-chain acyl-Coli dehydrogenase (MCAD) deficiency is a frequent and sometimes fatal inherited metabolic disorder of fatty acid &oxidation. eukaryotic espression system was used to study naturally occurring mutations in bICAD. Tho 1263 nuclcotide coding region of human hlCAD cDNA was inserted downstream of the SV40 early promoter for high-level expression in Chinese hamster ovary cells. Both normal hlCAD cDNA and a mutant MCAD cDNA containing the common, disease-causing A to G transition a t position 985 (A985G), which alters a lysine to a glutamic acid (K304E), were inserted into espression vectors. Transient transfection of Chinese hamster ovary cells was performed with the espression constructs. The steady state level of expressed normal hlCAD protein antigen was substantially higher (5-fold) than the expressed mutant protcin. The hlCiiD enzymatic activity in protein extracts from cells containing the expressed normal bICAD cDNA was also much higher (6-fold) than the activity in cells expressing the mutant ILICAD. Therefore, these data confirm that the common K304E mutation causes ILlCAD deficiency primarily by decreased protein stability rather than reduction of catalytic activity and, in fact, demonstrate that the K304E mutant protein has a similar sp act against octanoyl Coii substrate a s the normal protein. (Pediatr Res 34: 694-697, 1993) Abbreviations hlCAD, medium-chain acyl-Cot\ dehydrogcnase ACD, acyl-Coil dehydrogenase PCR, polymerase chain reaction CIIO, Chinese hamster ovary MCAD (2.3-oxidoreductase, EC 1.3.99.3 ) is a mitochondrial matrix flavoprotein that catalyzes the initial reaction in fatty acid @-oxidation (I). MCAD is one of three straight-chain ACD with distinct but overlapping fatty acyl substrate specificities (2). MCAD deficiency (3-5) is a relatively common disorder with an estimated frequency of 1 per 10 000-15 000 births in Northern Europe (6) (7) (8) . Clinical manifestations, generally first noted in early childhood, may include a Reye-like syndrome of recurrent hypoglycemia with coma (9. 10) or sudden death (1 1. 12). Based upon our characterization of the human MCAD mRNA (13) and gene (14) . we analyzed the MCAD mRNA of MCADdeficient individuals. We and others (15) (16) (17) (18) identified an A to G transition at position 985 (A985G) ofthe MCAD mRNA that causes a lysine to glutamate substitution at residue 304 (K304E) of the mature protein. This mutant allele is prcsent in over 90% of MCAD-deficient individuals in the United States and Europe (8, 19, 20) . This common mutation alters a basic residue to a negatively charged acidic residue, a change that could dramatically affcct the structure and therefore the catalytic function of the mutant enzyme. However, analysis of the crystal structure of tetramcric pig MCAD suggests that the mutation at amino acid 304 would not directly affcct the active site. Rather, this residue lies within the helices forming subunit interfaces and may thcrefore interfere with proper tetramcr assembly (2 1. 22 ) and protein stability.
Our initial characterization of the mutant (Glu'"') MCAD protein by Western blot analysis in patients' fibroblasts consistently revealed a normal-sized. immunoreactivc protein (13) with the lcvcls comparable to normal fibroblasts. However, in postmortem liver tissue. we observed that the mutant protein levels were markedly reduced (13) . raising the possibility that the mutant protein was rapidly degraded or that there is some tissucspecific variability of MCAD protein stability. Others initially examined the mutant protein with short-term labeling expcriments and found comparable amounts of newly synthesized immunoreactivc MCAD protcin in normal and MCAD-deficient fibroblasts (23) . With pulse-chase experiments, however, levels of K304E mutant protein were markedly decreased after 24 h (24). Although such studies suggest that protein instability is the major cause of MCAD dcficiency in patients with the K303E mutation, careful examination of K304E mutant enzyme activity was not performed.
After expression of the mutant enzyme in E.schc~ric11irr coli, we noted readily detectable MCAD on protcin immunoblots, but no enzymatic activity was detected (17) . However, most of the expressed MCAD protein was aggregated in inclusion bodies and improperly folded, making interpretation of the results problematic. Moreover, because bacteria lack mitochondria. neither the effect of the mutation on mitochondrial import nor the stability of the mutant protein in its normal mitochondrial environment could be examined. T o characterize adequately the mutant enzyme, we used expression of cDNA encoding MCAD in a eukaryotic system and report herein the effect of the K304E mutation on MCAD activity and stability. 1i'c.srcrrl hlor rtriu/jl.\is. Extracts from the transfected cells wcre prepared by three cycles of freezing and thawing in 250 pL of 0.25 mM Tris, pH 7.8, followed by sonication. Protein extract (25 pg) from each of the transfection experiments was separated on a 12.5% SDS polyacrylamide gel. The proteins were transferred to Immobilon (Millipore Corp., Bedford, MA) and incubated with anti-porcine MCAD (15) . An alkaline phosphatase calorimetric detection system (Promega) was used for visualization of the proteins.
ACD ucrivir!~ u.s.su!,. The enzymatic assays wcre performed as previously described (27) on cell pellets from each transfcction using electron transfer flavoprotcin as the electron acceptor.
Dct~.siror?~crric at~a/!:sis. An LKB ultrascan XL laser densitometer (LKB Instruments. Gaithersburg. MD) was used to quantify data from Western and RNA blots. All densitomctcr measurcments were within the linear response range of the instrument. RESULTS E.v~~re.s.siori c?f'rlorrrirrl (L!:s3"' ) utld I ) I I I I N~I~ (G11i3'1J) nfc,.ln in CHO cc1l.s. cDNA encoding precursor MCAD containing cithcr a n adenine (A985) or a guanine ((3985) at position 985 were inserted into the PSGS expression vector downstream of the SV40 early promoter (Fig. I) . The normal (PSG5-A985), mutant (PSG5-G985), or vector without any insert (PSGS-0, as a control) plasmids were transfected into C H O cclls. An SV40-@-Gal plasmid was cotransfected to correct for transfection efficiency. T o confirm appropriate transcription of the MCAD inserts and to compare levels of endogenous MCAD mRNA with those of transfected cells, total RNA was isolated from ccll pellets froni each of the three transfection experiments (PSG5-A985. PSGS-(3985, and PSG5-0). The transfection efficiencies with the three constructs were equivalent. Equal amounts of total RNA were analyzed by RNA blot analysis with a human MCAD cDNA probe (Fig. 2) . RNA from both the normal (PSG5-A985) and mutant (PSG5-G985) transfected cells demonstrated a single band corresponding in size to the expected expressed MCAD mRNA (-1.9 kb). Densitometric analysis of the autoradiogram revealed that the amounts of expressed normal and mutant MCAD mRNA were equivalent, demonstrating equally efficient transcription of both normal and mutant MCAD plasmids (data BamHI BamHI not shown). In contrast, no band was detected in the lane containing RNA from the PSG5-0 (vcctor alone) transfectcd cells, demonstrating that endogenous MCAD mRNA levels are very low in these cells.
T o assess the relative lcvcls of the expressed normal and mutant MCAD proteins in comparison with endogenous MCAD protein, immunoblot analysis with a polyclonal rabbit MCAD antibody was performed using total protein extracted from pooled cell pellets from each of the transfection experiments ( Fig.   696   WHELAN l,.T . -I ! . 
3). Extracts from cells containingeither normal or mutant ((3985)
MCAD cDNA demonstrated a single signal identical in size to the endogenous MCAD protein in control (PSG5-0) transfccted C H O cells. The levels of both the expressed normal MCAD and the expressed mutant (Glu3"') MCAD proteins wcre substantially higher than the levels of endogenous MCAD protein present in the control (PSG5-0) transfected cclls. Furthermore, the level of expressed normal MCAD protein was much higher than the expressed mutant MCAD protein. T o quantify the relative. steady state amounts of normal and mutant immunodetectablc protein, densitometric analysis of the immunoblot (Fig. 3) was performed. The level of immunodctcctable normal MCAD expressed was 5-fold greater than the expressed mutant (Glu3"') protein (data not shown).
ACD enz!?tnc uctivilj~ r?1c1u.sllrc~t~~ctlts c!fe\prc~s.scd tlort?~~I N~I C I
t?llrrut?r (Gllr"") AlCAD. ACD activities were determined in extracts from each of the three transfection experiments (PSG5-A985, PSG5-G985, and PSG5-0) using a fluorometric assay with electron transfer flavoprotein as the electron acceptor (Table 1) . Mean MCAD activity, as determined by the activity with octanoyl-CoA substrate, was 7-fold higher in the extract derived from cells transfected with normal MCAD cDNA (PSG5-A985) (72. After subtraction of the endogenous MCAD activity, the expressed normal MCAD had 6-fold higher activity than the expressed mutant MCAD. This degree of reduced MCAD activity in the cells with expressed mutant MCAD, as compared with the normal, was similar to the 5-fold reduction in immunodetectable MCAD antigen (Fig. 3) . Thus, calculated sp act of the mutant MCAD is similar to that of normal MCAD (Table 1) . DISCUSSION MCAD deficiency is a common and frequently fatal inherited metabolic defect. Although population and genetic studies are quite convincing that the "common mutation" (an A to G transition at nucleotide 985 that results in a lysine to glumatic acid change at position 304 of the protcin) is indeed a diseasccausing mutation, the results ( 1 3, 23. 24) regarding the basis of reduced enzyme activity in individuals homozygous for this mutation, which have used patients' fibroblasts. are incomplete and contradictory. We therefore chose to overexpress normal MCAD and the K304E mutant MCAD in C H O cells to better delineate whether the mechanism responsible for MCAD dcficiency is increased degradation rate of MCAD protcin, a decrease in MCAD sp act, or a combination of both. The results demonstrate equal levels of mRNA, indicating no diKcrcnces in synthcsis (plasmid transcription) or degradation between mutant and nornlal MCAD mRNA. The increased levels of normal-sized mature MCAD protcin in cells containing expressed normal MCAD comparcd with control cclls indicate that normal translation, mitochondria1 import. and cleavage ofthe leader or transit peptidc can occur in this eukaryotic expression system. Because cells containing the mutant MCAD cDNA also have increased amounts of mature MCAD protein comparcd with control cells. we conclude that the mutant MCAD protein can also be appropriately expressed. transported into mitochondria, and processed to the mature form. Moreover, this mutant protcin is suficiently long-livcd to allow detection of an increased amount of mutant protein compared with control cells. Similar results were obtained by Jensen t . 1 (11. (28) after transfection of wild-type and mutant MCAD into COS cells.
Several important conclusions can be drawn from the activity data. The marked increase in activity with octanoyl-CoA substrate sccn in cells containing wild-type (PSG5-A985) MCAD cDNA compared with control (PSG5-0) cells confirms that the increased MCAD protein seen on Western blot is catalytically active, and that this is an efficient and functional expression system. Furthermore, the increase in activity with octanoyl-CoA substrate in cells containing mutant MCAD cDNA comparcd with control cells demonstrates that the mutant protein has substantial enzymatic activity. In fact, the difference (6-fold) in activities of cxtracts from normal and mutant cells with octanoylCoA substrate very closely correlates with the difference in the relative amounts of MCAD protein on the Western blot (j-fold). Thus, the mutant MCAD protein has a very similar sp act (I. ? . activity per pg MCAD antigen) ~r,:vlr.s C8-CoA substratc to the normal protcin. In this assay of crude cxtracts, mutant MCAD is therefore as active as normal MCAD.
Taken together, our results demonstrate that the amount of mutant MCAD protein is reduced in these transfected cells, even though both mRNA are present in equal amounts. The most likely explanation for this result is that the mutant protein is more rapidly degraded than the normal MCAD. This conclusion is similar to that of Coates cr ril. (24) . who used fibroblasts from patients with the K304E mutation in pulse-chase experiments. and that of Jcnsen c. 1 uI. (28) in transfection experiments similar to ours. The apparent discrepancies with our earlier work (1 3) in mutant fibroblasts and the short-term labeling experiments of lkeda or (11. (23) suggest that MCAD protein half-life may vary with differing experimental conditions. However, these previous studies (13, 24, 28) did not estimate the relative sp act of the normal and mutant proteins, such that no conclusions concern- (2 1, 22 ) dcmonstratc that subunit interactions occur through the first 15 NH2-tcrminal rcsiducs. the final 10 C00li-terminal amino acids. thc flavin moieties of adjaccnt subunits, and the H and I hcliccs ncar thc COOH-terminus. If the rate of tctramcr formation wcrc rctardcd. it seems likcly that susceptibility to protcolysis would bc incrcascd bccausc the most stable conformation of MCAD subunits would not havc bccn achicvcd. The normal MCAD tetramcr is highly ordcrcd and cannot be rcformed after dcnaturation it1 13ilro. An altcrnative to csplain incrcascd MCAD degradation ratc is that the mutant protcin precursor is importcd into mitochondria less eficicntly than the normal MCAD and is degraded by cytosolic protcases. Because transient transfcction systems. such as that used licrc, d o not achicvc a prolonged steady state, we believe that stably transfectcd cell lines will be rcquircd to compare MCAD synthetic and dcgradativc rates and to examine thc intraccllular sitcs of mutant MCAD breakdown.
In summary, wc havc used a cukaryotic csprcssion systcm that should be easily adaptable for the study of mutations of mitochondrial oxidative enzymes including long-chain ACD, shortchain ACD, and additional naturally occurring MCAD mutations. We havc also confirmed. at the protcin level. that thc putative common MCAD mutation docs indeed causc MCAD dcficicncy and that the dclicicncy statc is due primarily to thc increased degradation ratc of mutant ratc MCAD protcin rathcr than to rcduccd sp act of the mutant enzyme. In fact, thc expressed mutant MCAD has a sp act similar to that of the normal protcin. 
